Published date: 30 December 2020
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Medical information systems - 48814000
Location of contract
Wales
Value of contract
£44,000
Procurement reference
tender_239054/915316
Published date
30 December 2020
Closing date
31 March 2020
Closing time
12am
Contract start date
1 April 2020
Contract end date
31 March 2022
Contract type
Service contract
Procedure type
Single tender action (below threshold)
A direct contract with a single supplier, without competition.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
This contract is a National Health Service (NHS) contract pursuant to section 9 of the NHS Act 2006 and sets out what Yellow Card promotion work the Provider will undertake each year, through a Yellow Card Centre, in return for payment from the Commissioner.
The aim of the Yellow Card scheme is to monitor the safety of the medicines and vaccines that are on the market.
The Yellow Card Scheme is vital in helping the MHRA monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and those that use them. Reports can be made for all medicines including vaccines, blood factors and immunoglobulins, herbal medicines and homeopathic remedies, and all medical devices available on the UK market.
The Scheme collects information on suspected problems or incidents involving
1.side effects (also known as adverse drug reactions or ADRs)
2.medical device adverse incidents
3.defective medicines (those that are not of an acceptable quality)
4.counterfeit or fake medicines or medical devices
It is important for people to report problems experienced with medicine or medical devices as these are used to identify issues which might not have been previously known about. The MHRA will review the product if necessary, and take action to minimise risk and maximise benefit to the patients. The MHRA is also able to investigate counterfeit or fake medicines or devices and if necessary take action to protect public health.
Wales Hub area.
Award information
Awarded date
31 March 2020
Contract start date
1 April 2020
Contract end date
31 March 2022
Total value of contract
£44,000
This contract was awarded to 1 supplier.
Cardiff and Vale NHS
Address
Department of Pharmacology Corridor, 2nd Floor, University Hospital of Wales, Heath Park, Cardiff CF14 4XW
Reference
No reference - other
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Medicines and Healthcare products Regulatory Agency - Procurement
Address
10 South Colonnade Canary Wharf
London
E14 4PU
England
Share this notice
Closing: 31 March 2020, 12am
All content is available under the
